Search Results - Matthew Mei

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Editorial: Advances in the treatment of Hodgkin lymphoma by Matthew Mei, Guilherme Perini, Radhakrishnan Ramchandren

    Published in Frontiers in Oncology (2023-02-01)
    Get full text
    Article


  2. 2

    Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit by Matthew Mei, Mehdi Hamadani, Kwang W. Ahn, Yue Chen, Mohamed A. Kharfan-Dabaja, Craig Sauter, Alex F. Herrera

    Published in Haematologica (2022-02-01)
    Get full text
    Article


  3. 3

    Role of Radiation in Combination With CD30-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Hodgkin Lymphoma by Colton Ladbury, MD, Claire Hao, BS, Matthew Mei, MD, Alex Herrera, MD, Garth Green, MD, Savita Dandapani, MD, PhD

    Published in Advances in Radiation Oncology (2024-04-01)
    Get full text
    Article


  4. 4

    P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma by Swetha Kambhampati, Matthew Mei, Lu Chen, Sandrine Puvurel, Robert Chen, Leslie Popplewell, Liana Nikolaenko, Lacolle Peters, Saro Armenian, Larry Kwak, Steven T. Rosen, Stephen Forman, Alex F. Herrera

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  5. 5

    P1200: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL): UPDATED RESULTS FROM THE PHASE 1 WAVELINE-001 STUDY by Stephen Spurgeon, Matthew Mei, Paul M. Barr, Jacqueline Barrientos, Sven de Vos, Richard Furman, Krish Patel, Philip Thompson, Michael Y. Choi, Avyakta Kallam, Siruo Wang, Uzor Ogbu, Patricia Marinello, Michael Wang

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  6. 6

    P112: Phase II Trial of Brentuximab Vedotin plus ibrutinib in Relapsed/Refractory Hodgkin Lymphoma by Matthew Mei, Joycelynne Palmer, Kami Maddocks, Peter Martin, Ni-Chun Tsai, Eileen Smith, Leslie Popplewell, Saro Armenian, Geoffrey Shouse, Robert Chen, Larry Kwak, Steven T. Rosen, Stephen Forman, David Bond, Alex F. Herrera

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


  7. 7

    Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia by Ibrahim Aldoss, Dongyun Yang, Ahmed Aribi, Haris Ali, Karamjeet Sandhu, Monzr M. Al Malki, Matthew Mei, Amandeep Salhotra, Samer Khaled, Ryotaro Nakamura, David Snyder, Margaret O’Donnell, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat

    Published in Haematologica (2018-09-01)
    Get full text
    Article


  8. 8

    Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents by Ibrahim Aldoss, Sanjeet Dadwal, Jianying Zhang, Bernard Tegtmeier, Matthew Mei, Shukaib Arslan, Monzr M. Al Malki, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet Sandhu, Samer Khaled, David Snyder, Ryotaro Nakamura, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat

    Published in Blood Advances (2019-12-01)
    Get full text
    Article


  9. 9

    Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell ther... by Colton Ladbury, Claire Hao, William Tyler Watkins, Sagus Sampath, Jeffrey Wong, Arya Amini, Karen Sokolov, Jekwon Yeh, Karine A. Al Feghali, Dorine de Jong, Arjun Maniyedath, Shervin Shirvani, Liana Nikolaenko, Matthew Mei, Alex Herrera, Leslie Popplewell, Lihua Elizabeth Budde, Savita Dandapani

    Published in Frontiers in Immunology (2024-10-01)
    Get full text
    Article


  10. 10

    Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma by James Godfrey, Matthew Mei, Lu Chen, Joo Y. Song, Victoria Bedell, Elizabeth Budde, Saro Armenian, Sandrine Puverel, Liana Nikolaenko, Robert Chen, Shari Daniels, Neena Kennedy, Lacolle Peters, Steven T. Rosen, Stephen J. Forman, Leslie L. Popplewell, Larry W. Kwak, Alex F. Herrera

    Published in Haematologica (2023-07-01)
    Get full text
    Article


  11. 11

    Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma by Surbhi Sidana, Hitomi Hosoya, Alexandria Jensen, Lawrence Liu, Anmol Goyal, Vanna Hovanky, Bita Sahaf, Sushma Bharadwaj, Theresa Latchford, Sally Arai, Sheryl Leahy, Matthew Mei, Lihua E. Budde, Lori S. Muffly, Matthew J. Frank, Saurabh Dahiya, Myo Htut, David Miklos, Murali Janakiram

    Published in Blood Cancer Journal (2023-10-01)
    Get full text
    Article


  12. 12

    Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high‐risk relapsed/refractory Hodgkin lymphoma by Matthew Mei, Joycelynne Palmer, Hun Ju Lee, Iris Isufi, Robert Chen, Ni‐Chun Tsai, Saro Armenian, James Godfrey, Joo Y. Song, John H. Baird, Swetha Thiruvengadam, Yazeed Samara, Jessica Flores, Lacolle Peters, Steven Rosen, Larry Kwak, Stephen J. Forman, Alex F. Herrera

    Published in HemaSphere (2025-05-01)
    Get full text
    Article


  13. 13

    Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transpl... by Ibrahim Aldoss, Tracey Stiller, Ni-Chun Tsai, Joo Y. Song, Thai Cao, N. Achini Bandara, Amandeep Salhotra, Samer Khaled, Ahmed Aribi, Monzr M. Al Malki, Matthew Mei, Haris Ali, Ricardo Spielberger, Margaret O’Donnell, David Snyder, Thomas Slavin, Ryotaro Nakamura, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat

    Published in Haematologica (2018-10-01)
    Get full text
    Article


  14. 14

    Impact of novel therapies on the efficacy of posttransplantation brentuximab vedotin maintenance in Hodgkin lymphoma by Ayo S. Falade, Robert Redd, Sanjal H. Desai, Alison J. Moskowitz, Harsh Shah, Susan M. Geyer, Nivetha Ganesan, Tiffany Chang, Tamer Othman, Gunjan L. Shah, Adrienne Nedved, Urshila Durani, Lay She Ng, Kelsey Baron, Shin Yeu Ong, Kevin Yoon, Stephen M. Ansell, Siddharth Iyengar, Ivana Micallef, Robert Stuver, Alex F. Herrera, Matthew Mei, Philippe Armand, Reid W. Merryman

    Published in Blood Advances (2026-06-01)
    Get full text
    Article


  15. 15

    The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation... by Matthew Mei, Raju Pillai, Soyoung Kim, Noel Estrada-Merly, Michelle Afkhami, Lixin Yang, Zhuo Meng, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Amer Beitinjaneh, Christopher Bredeson, Jean-Yves Cahn, Jan Cerny, Edward Copelan, Corey Cutler, Zachariah DeFilipp, Miguel Angel Diaz Perez, Nosha Farhadfar, César O. Freytes, Shahinaz M. Gadalla, Siddhartha Ganguly, Robert Peter Gale, Usama Gergis, Michael R. Grunwald, Betty K. Hamilton, Shahrukh Hashmi, Gerhard C. Hildebrandt, Hillard M. Lazarus, Mark Litzow, Reinhold Munker, Hemant S. Murthy, Sunita Nathan, Taiga Nishihori, Sagar S. Patel, David Rizzieri, Sachiko Seo, Mithun Vinod Shah, Melhem Solh, Leo F. Verdonck, Ravi Vij, Ronald M. Sobecks, Betul Oran, Bart L. Scott, Wael Saber, Ryotaro Nakamura

    Published in Haematologica (2022-04-01)
    Get full text
    Article


Search Tools: